Efficacy and Tolerance of Vascular Electrical Stimulation Therapy in the Management of Vaso-Occlusive Crises in Patients with Sickle Cell Disease: A Phase II Single-Centre Randomized Study in Ivory Coast

Table 1

Baseline patient characteristics (age, sex, genotype, pain location, and VAS admission score).

Parameters	Placebo (n = 10)	VEST (n = 10)	NSAID + VEST (n = 10)
Median age, years (range)	9 (17–20)	27 (18–36)	23 (22–27)	0.0752 NS
Sex, n (%)
Female	7 (70)	8 (80)	7 (70)	0.999 NS
Male	3 (30)	2 (20)	3 (30)
Phenotype, n (%)
SSFA2	1 (100)	0 (0)	0 (0)
SFA2	7 (44)	6 (38)	3 (19)	0.185 NS
SC	1 (10)	3 (30)	6 (60)
SAFA2	1 (33)	1 (33)	1 (33)
Pain location, n (%)
Arm	1 (20)	4 (80)	0 (0)	0.094 NS
Leg	7 (37)	5 (26)	7 (37)	0.709 NS
Back	2 (25)	2 (25)	4 (50)	0.668 NS
VAS Score at admission	10 (8–10)	9.5 (8–10)	9.5 (8–10)	0.5618 NS

NS, not significant; VAS, visual analogue score.